Pharmacy Market BUZZ

Market News, Products, Services, and Trends

Updates in the Treatment of Myelofibrosis: Pharmacist Focus on Improving Outcomes


To provide oncology, managed care and specialty pharmacists with advanced knowledge of how to optimally manage patients with myelofibrosis, such that they can identify and recommend appropriate patient-specific treatments that are cost-effective, develop optimal toxicity prevention and management, and to improve patient outcomes.


Upon completion of this program, participants should be better able to:

-Discuss the pathophysiology of myelofibrosis

-Examine current treatment options and emerging therapies for myelofibrosis

-Demonstrate effective approaches to prevent and manage adverse effects of therapies used to treat myelofibrosis

-Formulate strategies to determine appropriate recommendations for formulary management, drug-tier assignments and prior authorizations


This accredited activity has been designed for oncology, managed care, and specialty pharmacist.

Today's Posts